Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 19/74 ]
NYSE | Common Stock
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.
The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface.
It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation.
In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range.
Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 8, 23 | -2.38 Decreased by -142.86% | -2.07 Decreased by -14.98% |
| Aug 8, 23 | -0.29 Increased by +65.48% | -0.34 Increased by +14.71% |
| May 3, 23 | -0.45 Increased by +48.28% | -0.43 Decreased by -4.65% |
| Feb 23, 23 | -0.78 Decreased by -11.43% | -0.78 |
| Nov 2, 22 | -0.98 Decreased by -88.46% | -0.78 Decreased by -25.64% |
| Aug 3, 22 | -0.84 Decreased by -25.37% | -0.75 Decreased by -12.00% |
| May 4, 22 | -0.87 Decreased by -117.50% | -0.64 Decreased by -35.94% |
| Feb 24, 22 | -0.70 Decreased by -4.48% | -0.63 Decreased by -11.11% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 16.88 M Increased by +5.28% | -14.27 M Increased by +3.50% | Decreased by -84.52% Increased by +8.34% |
| Mar 31, 24 | 19.13 M Increased by +7.91% | -14.84 M Increased by +17.99% | Decreased by -77.54% Increased by +24.00% |
| Dec 31, 23 | 19.73 M Increased by +5.74% | -10.19 M Increased by +52.49% | Decreased by -51.61% Increased by +55.07% |
| Sep 30, 23 | 15.17 M Increased by +11.97% | -15.13 M Increased by +42.25% | Decreased by -99.76% Increased by +48.43% |
| Jun 30, 23 | 16.04 M Increased by +23.64% | -14.79 M Increased by +65.35% | Decreased by -92.21% Increased by +71.98% |
| Mar 31, 23 | 17.73 M Decreased by -18.00% | -18.09 M Increased by +21.14% | Decreased by -102.02% Increased by +3.83% |
| Dec 31, 22 | 18.66 M Decreased by -16.10% | -21.44 M Decreased by -15.50% | Decreased by -114.86% Decreased by -37.66% |
| Sep 30, 22 | 13.54 M Decreased by -64.46% | -26.20 M Decreased by -93.14% | Decreased by -193.44% Decreased by -443.48% |